Alzamend Neuro (ALZN) Earnings Date, Estimates & Call Transcripts $1.11 +0.05 (+4.72%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$1.07▼$1.1450-Day Range$1.00▼$26.2652-Week Range$0.96▼$16.95Volume113,715 shsAverage Volume41,204 shsMarket Capitalization$7.18 millionP/E RatioN/ADividend YieldN/APrice Target$22.50 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateDec. 11EstimatedActual EPS (Sep. 13) -$0.60 Missed By -$0.60 Get Alzamend Neuro Earnings AlertsEnter your email address below to receive the latest news and earnings results for ALZN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueALZN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALZN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Alzamend Neuro Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20231($0.07)($0.07)($0.07)Q3 20231($0.05)($0.05)($0.05)Q4 20231($0.05)($0.05)($0.05)ALZN Earnings Date and InformationAlzamend Neuro last released its earnings data on September 13th, 2023. The reported ($0.60) earnings per share (EPS) for the quarter. Alzamend Neuro has generated ($2.40) earnings per share over the last year (($2.40) diluted earnings per share). Alzamend Neuro has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 11th, 2023 based off prior year's report dates.Read More Alzamend Neuro Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 12/11/2023Estimated)------- 9/13/2023Q1 2024-($0.60)($0.60)($0.04)--7/27/2023Q4 2023-($0.45)($0.45)($0.03)--3/16/2023Q3 2023-($0.90)($0.90)($0.06)--12/12/2022Q2 2023-($0.45)($0.45)($0.03)--9/13/2022Q1 2023-($0.45)($0.45)($0.03)--7/19/2022Q4 2022-($0.75)($0.75)($0.05)-- Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 3/15/2022Q3 2022($0.30)($0.45)($0.15)($0.03)--12/12/2021Q2 2022($0.30)($0.60)($0.30)($0.04)--9/13/2021Q1 2022-($0.45)($0.45)($0.03)-- Alzamend Neuro Earnings - Frequently Asked Questions When is Alzamend Neuro's earnings date? Alzamend Neuro has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 11th, 2023 based off last year's report dates. Learn more on ALZN's earnings history. How much profit does Alzamend Neuro generate each year? Alzamend Neuro (NASDAQ:ALZN) has a recorded net income of -$14.88 million. ALZN has generated -$2.40 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Bio-Path Earnings Sunshine Biopharma Earnings RenovoRx Earnings Pasithea Therapeutics Earnings Lipella Pharmaceuticals Earnings Eterna Therapeutics Earnings Xenetic Biosciences Earnings Benitec Biopharma Earnings Cadrenal Therapeutics Earnings DMK Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Diamondback Energy: 7x earnings is an energy diamond in the roughSamsara's big rally: 27% surge following stellar Q3 earningsThe truth about Lululemon earnings: Suddenly in bearish crosshairOwn Dollar General? Hurry and take this advice before earningsEarnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings This page (NASDAQ:ALZN) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.